Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Israeli biopesticide company STK has received Philippine approval for its combined biological and chemical “hybrid” fungicide, Regev (Melaleuca alternifolia extract + difenoconazole).
ChemChina subsidiary Syngenta has introduced the fungicide, Orondis Gold Potato (oxathiapiprolin + metalaxyl-M), in Canada.
The Canadian Pest Management Regulatory Agency (PMRA) approved five new conventional pesticide active ingredients in the year ended March 31st 2018.
The US biopesticide company, Marrone Bio Innovations (MBI – Davis, California), has been awarded further US patent protection for its biofungicide, Bacillus amyloliquefaciens strain F727, which was developed as MBI-110.
The US crop protection company, Sym-Agro (Visalia, California), has launched a copper sulfate-based bactericide/fungicide, Instill, in the US state of California.
BASF has launched its preventive fungicide, Tessior (boscalid + pyraclostrobin - trade-marked as F500), in Spain.
The Canadian company, Vive Crop Protection (Toronto, Ontario), has received US approval for its azoxystrobin-based fungicide, AZteroid FC 3.3.
Fourteen agrochemical active ingredients are to have their approval periods extended by one to three years to allow more time for slow EU procedures for renewing the authorisations.
The withdrawal of support by applicants to renew EU approvals of five agrochemical active ingredients is to result in the cancellation of extensions to their current authorisation periods.
EU member states have voted in favour of the proposed approval of BASF’s new fungicide, mefentrifluconazole (trade-marked as Revysol).
The Canadian Pest Management Regulatory Agency (PMRA) has approved FMC's biofungicide/nematicide, F4018-4 (Bacillus subtilis strain FMCH002 + B licheniformis strain FMCH001).
BASF is to launch two fungicides, Axar Flowable (fluxapyroxad - trade-marked as Xemium + difenoconazole) and Imtrex Flowable (fluxapyroxad) in Japan.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.